Urinary albumin excretion rate and cardiovascular disease in Spaniard type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 36, Issue 2, 1997, Pages 127-134

  Relimpio, F ^a,b   Pumar, A ^a   Losada, F ^a   Molina, J ^a   Maynar, A ^a   Acosta, D ^a   Astorga, R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Ctro Especialidades Virgen los R   (Spain)

Author keywords

Coronary heart disease; Diabetes mellitus (non insulin dependent); Hypertension; Microalbuminuria

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEINURIA; RISK FACTOR; SPAIN; URIC ACID URINE LEVEL;

AGED; ALBUMINURIA; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN;

EID: 0030798177     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00043-0     Document Type: Article

References (22)

1. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth, M.R. Group, Diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial, Diabetes Care 16 (1993) 434-444.
2. M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in Whites and African-Americans. The atherosclerosis risk in communities baseline study, Diabetes Care 19 (1996) 414-418.
3. G.M. Reaven, Role of insulin resistance in human disease, Diabetes 37 (1988) 1595-1607.
4. R.A. DeFronzo, E. Ferranini, Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and other atherosclerotic cardiovascular disease, Diabetes Care 14 (1991) 173-194.
5. L. Groop, A. Ekstrand, C. Forsblom, E. Widen, P.H. Groop, A.M. Teppo, et al., Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia 36 (1993) 642-647.
6. A. Schmitz, M. Vaeth, Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients, Diabetic Med 5 (1988) 126-134.
7. W. Gatling, C. Knight, R.D. Hill, Screening for early diabetic nephropathy: Which sample to detect microalbuminuria?, Diabelic Med. 2 (1985) 451-455.
8. G. Bruno, P. Cavallo-Perin, G. Bargero, M. Borra, V. Calvi, N. D'Errico, et al., Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects, Diabetes Care 19 (1996) 43-47.
9. B. Feldt-Rasmussen, E.R. Mathiesen, Variability of urinary excretion in incipient diabetic nephropathy, Diabetic Nephropathy 3 (1984) 101-103.
10. Prospective Diabetes Study Group, UK, Urinary albumn excretion over three years in diet-trealed type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia, Diabetologia 36 (1993) 985-992.
11. M. Velussi, E. Brocco, F. Frigato, M. Zolli, B. Muollo, M. Maioli, et al., Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients, Diabetes 45 (1996) 216-222.
12. G. Crepaldi, A. Carraro, E. Brocco, L. Adezati, D. Andreani, G. Bompiani, et al., Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist, Acta Diabetol. 32 (1995) 203-208.
13. L.J. Dominguez, M. Barbagallo, W. Kattah, D. Garcia, J.R. Sowers, Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects, Am. J. Hypertens. 8 (1995) 808-814.
14. L. Niskanen, M. Uusitupa, H. Sarlund, O. Siitonen, E. Voutilainen, Y. Penttilä, K. Pyörälä, Microalbuminuria predicts the development of serum lipoprotein abnormalities favoring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, Diabetologia 33 (1990) 237-243.
15. J. Rubiés-Prat, J.L. Reverter, M. Senti, J. Pedro-Botet, I. Salinas, A. Lucas, et al., Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus, Diabetes Care 16 (1993) 1081-1086.
16. E.M. Damsgaard, C.E. Mogensen, Microalbuminuria in elderly hyperglycaemic patients and controls, Diabetic Med. 3 (1986) 430-435.
17. R. Klein, B.E.K. Klein, S.E. Moss, Prevalence of microalbuminuria in older-onset diabetes, Diabetes Care 16 (1993) 1325-1329.
18. J. Ruiz, J. Thillet, T. Huby, R.W. James, D. Erlich, P. Flandre, et al., Association of elevated lipoprotein (a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein (a) phenotypes, Diabetologia 37 (1994) 585-591.
19. A. Scanu, R.M. Lawn, K. Berg, Lipoprotein (a) and atherosclerosis, Ann. Int. Med. 115 (1991) 209-218.
20. A.J. Jenkins, J.S. Steele, E.D. Janus, J.D. Santamaria, J.D. Best, Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria, Diabetologia 35 (1992) 1055-1059.
21. N. Olivarius, A.H. Andreasen, N. Keiding, C.E. Mogensen, Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients: Cross-sectional data from the population-based study 'Diabetes care in general practice', Denmark, Diabetologia 36 (1993) 1007-1016.
22. D. Cassuto, A. Basdevant, T. Gibault, J.J. Altman, J. Raison, B. Guy-Grand, Microalbuminuria in obese subjects, Horm. Metab. Res. 24 (1992) 302-303.